23/08/2026
In 1910, Abraham Flexner published a report on the state of American medical education — commissioned and funded by the Carnegie Foundation, with significant involvement from the Rockefeller Foundation.
The Flexner Report concluded that most American medical schools were inadequate. It recommended standardisation around a German model of medicine — laboratory-based, pharmaceutical-oriented, and rooted in what became known as allopathic medicine.
The report's recommendations were adopted. Medical schools that did not meet the new standards lost funding and accreditation. Between 1910 and 1935: the number of medical schools in America fell from 155 to 66. Schools teaching herbal medicine, homeopathy, naturopathy, and other approaches to health were largely eliminated or marginalised.
The pharmaceutical orientation of the new medical model required: drugs. Drugs were derived increasingly from petrochemicals. John D. Rockefeller's Standard Oil was the primary source of petrochemical derivatives from which many pharmaceutical compounds were synthesised.
The Rockefeller Foundation simultaneously funded medical schools, funded pharmaceutical research, and held financial interests in companies that benefited from a pharmaceutical-based medical system.
This is documented in the foundation's own annual reports and in academic histories of medical education.
The alignment between the educational reform, the pharmaceutical model it promoted, and the industrial interests of its primary funder: has been examined by historians of medicine who have noted the structural conflict of interest.
No claim is made here that the Flexner Report was fraudulent. Much of what it recommended improved safety and rigour in medical education. The question historians ask: was the complete elimination of alternative approaches necessary — or convenient?
💬 The foundation that funded medical school standardisation had financial interests in the pharmaceutical industry those schools would rely on. That's documented. What do you think about who shapes what medicine looks like?